NOT-CA-16-068: Notice of Change in Application Due Dates for PAR-16-166 "Integrating Biospecimen Approaches into Clinical Assay Development (U01)"

Notice of Change in Application Due Dates for PAR-16-166 "Integrating Biospecimen Approaches into Clinical Assay Development (U01)"

Notice Number: NOT-CA-16-068

Key Dates
Release Date: September 1, 2016

Related Announcements
PAR-16-166

Issued by
National Cancer Institute (NCI)

Purpose

This Notice changes the Application Due Dates and other Key Dates for PAR-16-166, "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01)".

Part 1. Key Dates

Currently reads:

Application Due Date(s): June 22, 2016; June 22, 2017
Scientific Merit Review: September/October 2016; September/October 2017
Advisory Council Review: January 2017; January 2018
Earliest Start Date: April 2017; April 2018
Expiration Date: June 23, 2017

Modified to read:

Application Due Date(s): June 22, 2016; February 13, 2017; October 11, 2017; June 22, 2018
Scientific Merit Review: September/October 2016; June 2017; January 2018; September/October 2018
Advisory Council Review: January 2017; August 2017; May 2018; January 2019
Earliest Start Date: April 2017; December 2017; July 2018; April 2019
Expiration Date: June 23, 2018

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Abhi Rao, Ph.D.
National Cancer Institute
Telephone: 240-276-5715
Email: [email protected]